Related Experiment Videos
Study on cardioactive effects of brazilein
Yu Nan Zhao1, Yang Pan, Jia Lin Tao
1Laboratory of Pharmaceutical Sciences, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100-084, China.
Pharmacology
|December 2, 2005
Summary
Brazilein, a compound from Caesalpinia sappan, enhances heart muscle contraction (positive inotropic effect) by inhibiting Na(+),K(+)-ATPase. This mechanism suggests potential for developing safer heart medications compared to cardiac glycosides.
Area of Science:
- Pharmacology
- Cardiovascular Research
- Natural Products Chemistry
Background:
- Brazilein, a compound derived from Caesalpinia sappan, is available in high purity.
- Positive inotropic agents are crucial for managing heart failure.
Purpose of the Study:
- To investigate the cardiotonic effects of brazilein.
- To elucidate the mechanism of action underlying brazilein's positive inotropic effect.
- To compare brazilein's safety profile with cardiac glycosides.
Main Methods:
- Isolated cardiac tissue experiments to assess inotropic action and effects on heart rate and coronary perfusion.
- Treatment with propranolol to investigate beta-adrenoceptor involvement.
- In vitro analysis of Na(+),K(+)-ATPase inhibition in guinea pig erythrocytes.
- In vivo electrocardiogram studies in rats.
Main Results:
- Brazilein demonstrated a concentration-dependent positive inotropic effect with minimal impact on heart rate and coronary perfusion.
- The cardiotonic effect was independent of beta-adrenoceptor stimulation.
- Brazilein partially inhibited Na(+),K(+)-ATPase (approx. 50% maximum inhibition) with low affinity and K(+) antagonism.
- In vivo studies showed brazilein did not induce arrhythmias, unlike deslanoside.
Conclusions:
- Brazilein exerts its positive inotropic effect by inhibiting Na(+),K(+)-ATPase.
- Brazilein exhibits a potentially safer therapeutic profile than traditional cardiac glycosides.
- Brazilein serves as a structural model for developing novel inotropic drugs.